Women´s health refers to the health problems that are specific to women. It is associated with certain unique issues - menopause, pregnancy and conditions of the female organs. It also includes medical situations in which women face problems directly or indirectly related to their biology and due lack of access to medical treatment. Increased awareness campaigns by the government are some of the major attributes which drives the growth of the market. Moreover, increased research and developments are also some of the major factors which boost the growth of the market. However, limited awareness and less income levels in several developing countries are some of the major challenges which hinder the growth of the market.
Global Women´s Health Market: Key Players
The research study includes profiles of leading companies operating in the global women´s health market. Key players profiled in the report include: Bayer AG, Allergan, Merck & Co., Pfizer Inc., Amgen, Agile Therapeutics Inc., Ferring Pharmaceuticals, Mylan N.V., Lupin, and Blairex Laboratories. In October 2018, Mylan launched Medroxyprogesterone Acetate Injectable Suspension – generic drug for birth control.
Opportunities for the Global Women´s Health Market:
Some of the factors such as rising incidence of chronic health conditions among women, government initiatives to curb population growth, and growing demand for contraceptives to prevent unintended pregnancies are some of the major attributes which boost the growth of the market in the estimated forecasts period. Increasing health conditions are also some of the major attributes which accelerates the growth of the market.
Restrains for the Global Women´s Health Market:
Some of the factors such as lack of awareness among the consumers are likely to have an impact on the growth of the market. In addition, lack of use of the contraceptives is also some of the major attributes which hinder the growth of the market.
Region Wise, Global Women´s Health Market Analysis:
North America anticipated having the largest share in the market. This can be attributed to the increasing median age of first-time pregnancies, and increased healthcare spending in the US and Canada. Moreover, the increased awareness and understanding regarding contraceptives among American women and the easy access to modern contraception as compared to developing countries propel the market growth in this region.
Global Women´s Health Market: Product Analysis
- EVISTA
- XGEVA
- Prolia
- Mirena
- Zometa
- Reclast/Aclasta
- Minastrin 24 Fe
- NuvaRing
- FORTEO
- Premarin
- ACTONEL
- ORTHO TRI-CY LO (28)
Global Women´s Health Market: Application analysis
- Postmenopausal Osteoporosis
- Endometriosis
- Contraceptives
- Menopause
- Polycystic Ovary Syndrome
- Other Applications
Global Women´s Health Market: Region Analysis
- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- France
- Germany
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- ASEAN
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Colombia
- Rest of L.A.
- Middle East and Africa
- Turkey
- GCC
- UAE
- South Africa
- Rest of Middle East
